Responding to a lawsuit by Novartis (NVS), the U.S. Department of Justice has defended Medicare price negotiations, signaling ...

The U.S. Department of Justice has filed an appeals court brief supporting the right of Medicare officials to negotiate ...

The Trump administration is moving forward with the defense of a Biden-era plan that allows Medicare to negotiate drug prices ...

Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...

The bill would tie prescription drug prices to federally negotiated rates under a program passed in the 1990s.

David Ricks said drugs like Mounjaro and Zepbound are priced to reflect the costs involved, patent expiry, and the enormous ...

fair prices it arrived in negotiations with drug makers for the first 10 medications selected. When former President Biden signed the Inflation Reduction Act into law in 2022, he said that drug ...

That leap forward came at a sky-high price: more than $2 million per dose, making Zolgensma then the costliest one-time treatment ever. How did a drug rooted, like many, in seed money from the U.S ...

PhRMA CEO Steve Ubl discusses, PBM reform, the "pill penalty" with the administration and advocating for pharmaceutical ...

Pharmacy benefits managers, or PBMs, are meant to act as a middleman between drug manufacturers and insurance companies to ...

The son-in-law of a Mexican drug lord entered a guilty plea over an 11-year price-fixing scheme that used deadly force along ...

As DFL Sen. Amy Klobuchar’s staff facilitated a conversation around staffing at health care and assisted living facilities ...